Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal midazolam before urodynamic testing in women
IRCT20210122050105N1Phase 4Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of midazolam in Urinary System Diseases ((none)) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Patient pain during urodynamic testing, Patient stress during urodynamic testing and 1 more. Started Feb 2021; status: completed.
02
Drugs
midazolam
03
Conditions
Urinary System Diseases ((none))
Beyond the preview
Go deeper on IRCT20210122050105N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210122050105N1.